Lituanie - lituanien - SMCA (Valstybinė vaistų kontrolės tarnyba)

zentiva k.s. - salmeterolis/flutikazono propionatas - dozuoti įkvepiamieji milteliai - 50 µg/100 µg/dozėje - salmeterol and fluticasone

Lituanie - lituanien - SMCA (Valstybinė vaistų kontrolės tarnyba)

zentiva k.s. - salmeterolis/flutikazono propionatas - dozuoti įkvepiamieji milteliai - 50 µg/250 µg/dozėje - salmeterol and fluticasone

Lituanie - lituanien - SMCA (Valstybinė vaistų kontrolės tarnyba)

zentiva k.s. - salmeterolis/flutikazono propionatas - dozuoti įkvepiamieji milteliai - 50 µg/500 µg/dozėje - salmeterol and fluticasone

Union européenne - lituanien - EMA (European Medicines Agency)

biocryst ireland limited - berotralstat dihydrochloride - angioedema, paveldima - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.

Union européenne - lituanien - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

Union européenne - lituanien - EMA (European Medicines Agency)

billev pharma aps - lutetium (177lu) chloride - radionuklidų vaizdavimas - terapiniai radiofarmaciniai preparatai - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.

Union européenne - lituanien - EMA (European Medicines Agency)

novartis europharm limited  - gozetotide - radionuklidų vaizdavimas - diagnostikos radiofarmaciniai preparatai - Šis vaistas yra skirtas tik diagnostikai. locametz, after radiolabelling with gallium 68, is indicated for the detection of prostate specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high risk pca prior to primary curative therapy,suspected pca recurrence in patients with increasing levels of serum prostate specific antigen (psa) after primary curative therapy,identification of patients with psma positive progressive metastatic castration resistant prostate cancer (mcrpc) for whom psma targeted therapy is indicated (see section 4.

Lituanie - lituanien - SMCA (Valstybinė vaistų kontrolės tarnyba)

solenis switzerland gmbh, mühlentalstrasse 38, 8200 schaffhausen, Šveicarija. - monochloraminas, gaunamas in situ iš amonio sulfato ir chloro šaltinio. - veikliosios medžiagos cas nr.: -, eb nr.: -, veikliosios medžiagos pavadinimas: monochloraminas, gaunamas in situ iš amonio sulfato ir chloro šaltinio., koncentracija: 0.5% , veiklioji